Novartis
Traded as NYSE: NVS
Industry Drug Manufacturers – Major
Founded 1996
Headquarters Basel 4056, Switzerland
CEO
Mr. Joseph Jimenez
Revenue US$ 50.387 billion
Operating income
US$ 8.977 billion
Net income
US$ 17.794 billion
Total assets US$ 131.556 billion
Total equity US$ 77.046 billion
Number of employees
118.000
Website Novartis.com
Source
Novartis.com/news/annual-report-2015

About:

 

Novartis AG,

is a biotechnology and pharmaceutical company based in Basel, Switzerland. The company was created in 1996 from the merger of “Ciba-Geigy AG” and “Sandoz”. Novartis goes back to several Basler tar-colour producers who joined together over the time to Novartis. Today, Novartis is the world’s largest pharmaceutical company and has, under the current CEO Joseph Jimenez, 118000 employees and a revenue of 50.387 billion USD.

Operation divisions: Pharmaceuticals (Consumer health and animal health)

Since 1996, Novartis has engaged in a number of M&A deals: 106 transactions with a value of  USD 107.83 bil. (for number and value per year, see figure below).

M&A Novartis

Top 10 Deals Novartis

RankDateTargetNationValue (in bil. USD)
104.07.2008Alcon IncSwitzerland27.73
204.22.2014GlaxoSmithKline PLC0OncologyUnited Kingdom16.00
301.04.2010Alcon IncSwitzerland12.14
404.07.2008Alcon IncSwitzerland10.55
509.01.2005Chiron CorpUnited States6.21
602.21.2005Hexal AGGermany5.68
712.02.1999AstraZeneca PLC0AgrochemicalsSwitzerland5.06
805.07.2001Roche Holding AGSwitzerland2.79
912.31.2002Roche Holding AGSwitzerland2.58
1002.21.2005Eon Labs IncUnited States1.70